Loading organizations...
§ Private Profile · La Jolla, CA, USA
Non-invasive genetic testing for precision medicine and tumor diagnosis.
Singlera Genomics has raised $125.0M across 3 funding rounds.
Singlera Genomics has raised $125.0M in total across 3 funding rounds.
Singlera Genomics has raised $125.0M in total across 3 funding rounds.
Singlera Genomics's investors include Green Pine Capital Partners, Prosperico Ventures, Jointown Pharmaceutical Group, Lilly Asia Ventures, UCF Medical Investment, Fei Chen, CDBI Partners.
Singlera Genomics has raised $125.0M across 3 funding rounds. Most recently, it raised $45.0M Singlera - Series B in June 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 8, 2022 | $45M Series B | — | — | Announced |
| Mar 28, 2018 | $60M Series A | Green Pine Capital Partners, Prosperico Ventures | Jointown Pharmaceutical Group, Lilly Asia Ventures, UCF Medical Investment | Announced |
| Aug 22, 2016 | $20M Series A | FEI Chen | CDBI Partners, Green Pine Capital Partners | Announced |